These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30941708)

  • 1. Review of Direct Oral Anticoagulants and Guide for Effective Drug Utilization.
    Khachatryan T; Hauschild C; Hoff J; Contractor T; Khachatryan A; Tran H; Matsuo B; Jacobson A; Hilliard A
    Am J Cardiovasc Drugs; 2019 Dec; 19(6):525-539. PubMed ID: 30941708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel anticoagulants for stroke prevention in patients with atrial fibrillation.
    Jalota A; Scarabelli TM; Saravolatz L; Bakhsh MU; Agrawal P; Jalota R; Chen-Scarabelli C; Fuster V; Halperin J
    Cardiovasc Drugs Ther; 2014 Jun; 28(3):247-62. PubMed ID: 24842559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential cellular effects of old and new oral anticoagulants: consequences to the genesis and progression of atherosclerosis.
    Schurgers LJ; Spronk HM
    Thromb Haemost; 2014 Nov; 112(5):909-17. PubMed ID: 25298033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
    Alamneh EA; Chalmers L; Bereznicki LR
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment with oral anticoagulants in older patients: Should warfarin still be prescribed?].
    Lafuente-Lafuente C; Oasi C; Belmin J
    Presse Med; 2019 Feb; 48(2):154-164. PubMed ID: 30528147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency department management of patients taking direct oral anticoagulant agents.
    Maher P; Taub E
    Emerg Med Pract; 2019 Aug; 21(8):1-28. PubMed ID: 31339254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.
    Eek AK; Øie E; Granas AG
    Eur J Clin Pharmacol; 2018 Mar; 74(3):323-330. PubMed ID: 29149366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement and reversal of the direct oral anticoagulants.
    Samuelson BT; Cuker A
    Blood Rev; 2017 Jan; 31(1):77-84. PubMed ID: 27625113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials.
    Chai-Adisaksopha C; Hillis C; Isayama T; Lim W; Iorio A; Crowther M
    J Thromb Haemost; 2015 Nov; 13(11):2012-20. PubMed ID: 26356595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Large studies of NOAC shows good and safe stroke protection].
    Hijazi Z; Oldgren J
    Lakartidningen; 2015 Sep; 112():. PubMed ID: 26348046
    [No Abstract]   [Full Text] [Related]  

  • 11. Three-Year Clinical Outcomes Associated With Warfarin vs. Direct Oral Anticoagulant Use Among Japanese Patients With Atrial Fibrillation　- Findings From the SAKURA AF Registry.
    Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Hanada S; Nomoto K; Arima K; Takahashi F; Kotani T; Ikeya Y; Fukushima S; Itou S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A;
    Circ J; 2018 Sep; 82(10):2500-2509. PubMed ID: 30078823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor Xa inhibitors: a novel therapeutic class for the treatment of nonvalvular atrial fibrillation.
    McCarty D; Robinson A
    Ther Adv Cardiovasc Dis; 2016 Feb; 10(1):37-49. PubMed ID: 26378211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation.
    Ment J
    Vasc Health Risk Manag; 2015; 11():317-32. PubMed ID: 26089678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants.
    Enriquez A; Lip GY; Baranchuk A
    Europace; 2016 Jul; 18(7):955-64. PubMed ID: 25816811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New oral anticoagulants in patients with atrial fibrillation in a urban health center].
    Rodríguez Pérez L; Capilla Lozano F; Gallego Fuentes R; Buitrago F
    Med Clin (Barc); 2016 Mar; 146(6):280-1. PubMed ID: 26343157
    [No Abstract]   [Full Text] [Related]  

  • 16. Target-specific oral anticoagulants in patients undergoing cardioversion.
    Law EH; Gordon W
    Am J Health Syst Pharm; 2014 Jul; 71(14):1171-6. PubMed ID: 24973374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian intersociety consensus on DOAC use in internal medicine.
    Prisco D; Ageno W; Becattini C; D'Angelo A; Davì G; De Cristofaro R; Dentali F; Di Minno G; Falanga A; Gussoni G; Masotti L; Palareti G; Pignatelli P; Santi RM; Santilli F; Silingardi M; Tufano A; Violi F; ; ;
    Intern Emerg Med; 2017 Apr; 12(3):387-406. PubMed ID: 28191610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monitoring options and reversal agents for oral anticoagulants].
    Thorup SB; Husted SE; Vang ML
    Ugeskr Laeger; 2014 Apr; 176(9):. PubMed ID: 25096568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation.
    Zirlik A; Bode C
    J Thromb Thrombolysis; 2017 Apr; 43(3):365-379. PubMed ID: 27896543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Old versus new oral anticoagulants: focus on pharmacology.
    Fareed J; Thethi I; Hoppensteadt D
    Annu Rev Pharmacol Toxicol; 2012; 52():79-99. PubMed ID: 21819239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.